{"doi":"10.1093\/pubmed","coreId":"136925","oai":"oai:bradscholars.brad.ac.uk:10454\/4666","identifiers":["oai:bradscholars.brad.ac.uk:10454\/4666","10.1093\/pubmed"],"title":"Explanations for variations in clopidogrel prescribing in England.","authors":["Petty, Duncan R.","Silcock, Jonathan"],"enrichments":{"references":[],"documentType":{"type":null}},"contributors":[],"datePublished":"2011-01-05T14:45:48Z","abstract":"noThe National Audit Office (NAO) has produced prescribing indicators that Primary Care Trusts (PCTs) can use to judge their\\ud\nperformance. One of the indicators is for the antiplatelet clopidogrel, measured as defined daily dose (DDD) per cardiovascular Specific\\ud\nTherapeutic Age Related Prescribing Unit (STAR-PU). Clopidogrel is used as an indicator because it is a more expensive medicine than the\\ud\nalternative (aspirin) and there may be scope for cost reduction. We aimed to establish if the NAO indicator for clopidogrel prescribing is a valid\\ud\nmeasure of prescribing performance.\\ud\nMethods Prescribing data for 152 PCTs and a range of explanatory variables were obtained. Correlation between variables was determined.\\ud\nA regression analysis was conducted to compare the dependent variable (prescribing) with the explanatory variables identified.\\ud\nResults The percentage of patients on the coronary heart disease register and Index of Multiple Deprivation explained 30% of the variation\\ud\nin prescribing (DDD\/STAR-PU) between PCTs. Even though DDD\/STAR-PU is adjusted for age and sex other measures of need still have\\ud\nan impact on prescribing.\\ud\nConclusions Using DDD\/STAR-PU alone as a prescribing indicator might misidentify some PCTs, which are under- and over-using clopidogrel.\\ud\nPoor ranking against other PCTs using the NAO indicator should be fully explored taking into account other variables (cardiovascular morbidity and\\ud\ndeprivation) before any corrective action is taken","downloadUrl":"","fullTextIdentifier":null,"pdfHashValue":null,"publisher":null,"rawRecordXml":"<record><header><identifier>\n        \n            \n                oai:bradscholars.brad.ac.uk:10454\/4666<\/identifier><datestamp>\n                2014-05-19T14:55:47Z<\/datestamp><setSpec>\n                com_10454_152<\/setSpec><setSpec>\n                col_10454_6342<\/setSpec>\n            <\/header><metadata><oai_dc:dc xmlns:oai_dc=\"http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc\/\" xmlns:dc=\"http:\/\/purl.org\/dc\/elements\/1.1\/\" xmlns:doc=\"http:\/\/www.lyncode.com\/xoai\" xmlns:xsi=\"http:\/\/www.w3.org\/2001\/XMLSchema-instance\" xsi:schemaLocation=\"http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc\/ http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc.xsd\" ><dc:title>\n            \nExplanations for variations in clopidogrel prescribing in England.<\/dc:title><dc:creator>\nPetty, Duncan R.<\/dc:creator><dc:creator>\nSilcock, Jonathan<\/dc:creator><dc:subject>\nPrescribing<\/dc:subject><dc:subject>\nEconomics<\/dc:subject><dc:subject>\nPrimary care<\/dc:subject><dc:subject>\nCardiovascular disease<\/dc:subject><dc:subject>\nClopidogrel<\/dc:subject><dc:description>\nno<\/dc:description><dc:description>\nThe National Audit Office (NAO) has produced prescribing indicators that Primary Care Trusts (PCTs) can use to judge their\\ud\nperformance. One of the indicators is for the antiplatelet clopidogrel, measured as defined daily dose (DDD) per cardiovascular Specific\\ud\nTherapeutic Age Related Prescribing Unit (STAR-PU). Clopidogrel is used as an indicator because it is a more expensive medicine than the\\ud\nalternative (aspirin) and there may be scope for cost reduction. We aimed to establish if the NAO indicator for clopidogrel prescribing is a valid\\ud\nmeasure of prescribing performance.\\ud\nMethods Prescribing data for 152 PCTs and a range of explanatory variables were obtained. Correlation between variables was determined.\\ud\nA regression analysis was conducted to compare the dependent variable (prescribing) with the explanatory variables identified.\\ud\nResults The percentage of patients on the coronary heart disease register and Index of Multiple Deprivation explained 30% of the variation\\ud\nin prescribing (DDD\/STAR-PU) between PCTs. Even though DDD\/STAR-PU is adjusted for age and sex other measures of need still have\\ud\nan impact on prescribing.\\ud\nConclusions Using DDD\/STAR-PU alone as a prescribing indicator might misidentify some PCTs, which are under- and over-using clopidogrel.\\ud\nPoor ranking against other PCTs using the NAO indicator should be fully explored taking into account other variables (cardiovascular morbidity and\\ud\ndeprivation) before any corrective action is taken.<\/dc:description><dc:date>\n2011-01-05T14:45:48Z<\/dc:date><dc:date>\n2011-01-05T14:45:48Z<\/dc:date><dc:date>\n2011-01-05T14:45:48Z<\/dc:date><dc:type>\nArticle<\/dc:type><dc:identifier>\nPetty, D. R. and Silcock, J. (2008). Explanations for variations in clopidogrel prescribing in England. Journal of Public Health, Vol. 30, No. 4, pp. 494-498. Oxford Journals. ISSN 1741-3842.<\/dc:identifier><dc:identifier>\n90011716<\/dc:identifier><dc:identifier>\nhttp:\/\/hdl.handle.net\/10454\/4666<\/dc:identifier><dc:identifier>\nJournal of Public Health 2008; 30: 494-498<\/dc:identifier><dc:language>\nen<\/dc:language><dc:relation>\nhttp:\/\/dx.doi.org\/10.1093\/pubmed\/fdn048<\/dc:relation>\n<\/oai_dc:dc>\n<\/metadata>\n        <\/record>","journals":null,"language":null,"relations":["http:\/\/dx.doi.org\/10.1093\/pubmed\/fdn048"],"year":2011,"topics":["Prescribing","Economics","Primary care","Cardiovascular disease","Clopidogrel"],"subject":["Article"],"fullText":null}